Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
11/2012
11/27/2012US8318689 SiRNA-based cancer treatment
11/27/2012US8318681 Utilization of peptides as active ingredients for slimming
11/27/2012US8318676 Use of agents containing creatine, creatinine and/or their derivatives to fortify and improve the structure of keratinic fibers
11/27/2012US8318186 Use of at least a fatty ester for preparing a composition designed to inhibit 5-α-reductase activity, in pharmacology, in particular dermatology, in cosmetics and as food additive
11/27/2012CA2738861C Photosensitizer composition for treating skin disorders
11/27/2012CA2581934C Stretch mark treatment with botulinum toxin
11/27/2012CA2556815C Skincare compositions comprising salicylic acid
11/27/2012CA2531505C (20s)-1.alpha.-hydroxy-2-methylene-19-nor-vitamin d3 and its uses
11/27/2012CA2516458C Use of kahalalide compounds for the manufacture of a medicament for the treatment of psoriasis
11/27/2012CA2481390C Nanoparticulate megestrol formulations
11/27/2012CA2414247C Cosmetic composition and method comprising a hydroxamate mmpi and a triterpenoid glycoside
11/27/2012CA2333755C The use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals
11/22/2012WO2012158312A2 Skin and hair regeneration using polysaccharide-based hydrogels
11/22/2012WO2012157817A1 Acne treatment composition using mal
11/22/2012WO2012157734A1 Wrinkle-improving composition containing placenta-derived component
11/22/2012WO2012157674A1 Cyclic peptide compound or pharmacologically acceptable salt thereof, method for producing cyclic peptide compound or pharmacologically acceptable salt thereof, and use of cyclic peptide compound or pharmacologically acceptable salt thereof
11/22/2012WO2012157587A1 Anti-wrinkle agent, matrix metalloproteinase (mmp) inhibitor and/or laminin 5 production promoter, each comprising 1-piperidine propionate
11/22/2012WO2012157479A1 Ctrp6 which can be used as therapeutic and prophylactic agent for autoimmune diseases
11/22/2012WO2012156927A1 Method to modulate pigmentation process in the melanocytes of skin
11/22/2012WO2012156917A2 Method for obtaining epsilon-viniferin and/or resveratrol and corresponding products
11/22/2012WO2012156877A1 Epicutaneous. skin cancer, basal, squamous, melanoma, collagen, procolla1, mmp1
11/22/2012WO2012156319A1 Novel anti-redness active agent and cosmetic compositions comprising same
11/22/2012WO2012156275A1 Compositions containing resveratrol and essential oil of cloves for the treatment of itching
11/22/2012WO2012131676A4 Method for treating disorders of the skin
11/22/2012WO2012122082A9 Methods for activating caspase-14 expression in human skin
11/22/2012WO2012112796A3 Perfluoro(n-butylcyclohexane) compositions and uses thereof
11/22/2012WO2012099899A3 Topical dermatological compositions for the treatment of acne
11/22/2012WO2012096463A3 Composition containing a mixed herbal extract as an active ingredient for preventing and improving allergic or non-allergic skin disease, and uses thereof
11/22/2012WO2012088382A3 Amyris alcohol and its ester for treating acne
11/22/2012US20120296263 Topical aminolevulinic acid-photodynamic therapy for the treatment of acne vulgaris
11/22/2012US20120296088 Synthesis of udp-glucose: n-acylsphingosine glucosyl transferase inhibitors
11/22/2012US20120295956 Prevention of tissue ischemia and related methods
11/22/2012US20120295953 Treatment of tumor protein 63 (p63) related diseases by inhibition of natural antisense transcript to p63
11/22/2012US20120295952 Treatment of filaggrin (flg) related diseases by modulation of flg expression and activity
11/22/2012US20120295947 Processes for the preparation of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid and salts thereof
11/22/2012US20120295942 Pyrazolo[5,1b]oxazole Derivatives as CRF-1 Receptor Antagonists
11/22/2012US20120295929 Compositions and methods for treating and preventing dermatoses
11/22/2012US20120295924 Thienopyrimidinedione derivatives as trpa1 modulators
11/22/2012US20120295914 Combination of adrenergic receptor agonist alpha-1 or alpha-2, preferably brimonidine with fillers, preferably hyaluronic acid
11/22/2012US20120295906 Pyridyl-and pyrimidinyl-substituted pyrrole-, thiophene-and furane-derivatives as kinase inhibitors
11/22/2012US20120295902 Hetaryl-[1,8]naphthyridine derivatives
11/22/2012US20120295900 1,3-oxazines as bace 1 and/or bace2 inhibitors
11/22/2012US20120295897 Spiro-oxindole compounds and their uses as therapeutic agents
11/22/2012US20120295889 3-Arylamino Pyridine Derivatives
11/22/2012US20120295877 Therapeutic Compounds
11/22/2012US20120295856 Fredericamycin derivatives
11/22/2012US20120295854 Methods of Inducing Tissue Regeneration
11/22/2012US20120295845 Imidazo-pyrazoles as gpr119 inhibitors
11/22/2012US20120294946 Modulator
11/22/2012US20120294933 Use of PVP-Iodine Liposomes for Treatment of Acne
11/22/2012US20120294928 Method of treating scars and b-catenin-mediated disorders using nefopam compounds
11/22/2012US20120294927 Wound dressing
11/22/2012US20120294926 Two or more volatile solvent-containing compositions and methods for dermal delivery of drugs
11/22/2012US20120294907 Two or more solidifying agent-containing compositions and methods for dermal delivery of drugs
11/22/2012US20120294895 Protein a compositions and methods of use
11/22/2012US20120294888 Tolerogenic synthetic nanocarriers for allergy therapy
11/22/2012US20120294887 Solid/liquid extraction
11/22/2012US20120294877 Epitope peptides derived from vascular endothelial growth factor receptor 1 and vaccines containing these peptides
11/22/2012US20120294854 Amino nicotinic and isonicotinic acid derivatives as dhodh inhibitors
11/22/2012US20120294849 Use of wf10 for treating allergic asthma, allergic rhinitis and atopic dermatitis
11/22/2012US20120294844 Methods And Kits For Topical Application, Removal, And Inactivation Of Therapeutic Or Cosmetic Toxin Compositions
11/22/2012US20120294841 Probiotic microorganisms as active agents against changes in the skin's microrelief
11/22/2012US20120294838 Regulation of endogenous gene expression in cells using zinc finger proteins
11/22/2012US20120294827 Polymer gel formulation
11/22/2012US20120294823 Method for preparing silk sericin-PVA scaffold using genipin as crosslinking agent
11/22/2012US20120294797 Anti-cgrp compositions and use thereof
11/22/2012CA2836249A1 Method to modulate pigmentation process in the melanocytes of skin
11/22/2012CA2834813A1 Skin and hair regeneration using polysaccharide-based hydrogels
11/22/2012CA2834710A1 Compositions and methods for the treatment of skin diseases
11/21/2012EP2524686A1 Pigmentation-preventing or -ameliorating agent
11/21/2012EP2524038A1 Modulation of transforming growth factor-beta 1 expression
11/21/2012EP2523957A1 Tricyclic heterocyclic compounds, compositions and methods of use thereof
11/21/2012EP2523688A1 Antibody formulation and therapeutic regimens
11/21/2012EP2523670A1 Method for producing reservoir layer for hoof treatment and reservoir layer
11/21/2012EP2523667A2 Lyophilized cake formulations
11/21/2012CN102791712A Pyrazolopyrimidine derivative
11/21/2012CN102791284A Method of treatment or prevention of hair loss or for the enhancement of hair growth
11/21/2012CN102786493A 2,3-diaryl thiazolidinone compound and analogue, and purpose thereof in preparing antiangiogenic drugs
11/21/2012CN102784387A Modified mutant collagenase and it's use in fat melting and in scar reduction
11/21/2012CN102784375A Externally-used traditional Chinese medicament for treating chilblain and preparation method of same
11/21/2012CN102784369A Capsule preparation for treating skin rubella
11/21/2012CN102784355A First-aid drug and its preparation method
11/21/2012CN102784352A Agent for treating psoriasis vulgaris
11/21/2012CN102784343A External use traditional Chinese medicine preparation for treating psoriasis
11/21/2012CN102784341A External use medicine for treating psoriasis and preparation method of medicine
11/21/2012CN102784340A Traditional Chinese medicine composition for treating children eczema
11/21/2012CN102784337A Traditional Chinese medicine compound lotion for treating exudative infantile eczema and preparation method thereof
11/21/2012CN102784336A Traditional Chinese medicine compound lotion for clearing away heat and toxic materials and promoting diuresis and relieving itching and preparation method
11/21/2012CN102784335A Traditional Chinese medicine compound lotion for treating urticaria papulosa and preparation method thereof
11/21/2012CN102784334A Traditional Chinese medicine compound lotion for treating seborrheic infantile eczema and preparation method
11/21/2012CN102784333A Traditional Chinese medicine composition for curing eczema
11/21/2012CN102784330A Outside traditional Chinese medicine lotion for treating acne
11/21/2012CN102784316A Cancer inhibition and flesh engendering medicine for treating burns, scalds, internal and external ulcer and cataract, and its preparation method
11/21/2012CN102784299A External use ointment for promoting wound healing without scar pigment and preparation method of external use ointment
11/21/2012CN102784296A Fructus trichosanthis oral liquid
11/21/2012CN102784274A Medicine for treating and nursing diabetic feet
11/21/2012CN102784266A Traditional Chinese medicine composition for treating chloasma
11/21/2012CN102784259A Externally-applied medicament for treating red and swelling furunculosis
11/21/2012CN102784246A Orally-administrated traditional Chinese medicine for treating acute eczema
11/21/2012CN102784245A Erding granule and preparation method thereof
1 ... 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 ... 1065